期刊文献+

STAT3基因siRNA表达载体的构建及鉴定 被引量:1

The Building and Identification of siRNA STAT3 Gene Expression Vector
下载PDF
导出
摘要 目的利用RNA干扰技术,以信号转导和转录激活因子3(STAT3)为靶基因,设计构建重组体,并进行序列分析鉴定。方法设计一条有小发夹结构的DNA序列,聚合酶链反应(PCR)扩增合成siRNA表达框架(SECs)表达框架,克隆至载体psi Lent GeneTM中构建重组体,转化E.coli DH5α菌株,提取质粒进行酶切鉴定后测序分析。结果重组质粒经EcoRⅤ酶切、电泳、测序分析表明插入序列正确,重组质粒构建成功。结论成功构建了STAT3靶向RNA干扰重组体,为肿瘤的基因治疗在分子水平、细胞水平和整体水平的研究提供一些新方法。 Objective This study used RNA interference technology,selected STAT3 gene as the target,and then design and construction a recombinant vector and then identification the gene sequence analysis. Methods Design a DNA sequence with a small hairpin structure,PCR amplification a siRNA expression cassettes,cloning vector to construct recombinants in psi Lent Gene TM into E. coli DH5α strain,extract plasmid after enzyme digestion sequencing. Results Recombinant plasmid by EcoR Ⅴ enzyme,electrophoresis and Sequencing analysis showed that the inserted sequence is correct,the recombinant plasmids were successfully constructed. Conclusion The successful construction of STAT3 targeted RNA interference recombinant,provides some new methods for gene therapy of cancer research at the molecular level,cellular level and the overall level of.
出处 《医学综述》 2015年第4期715-718,共4页 Medical Recapitulate
基金 武警医学院总部级科研项目(WKH2006-6)
关键词 信号转导和转录激活因子3 RNA干扰 质粒 Signal transduction and activators of transcription3 RNA interference Plasmid
  • 相关文献

参考文献5

二级参考文献77

  • 1Roel NUSSE.Wnt signaling in disease and in development[J].Cell Research,2005,15(1):28-32. 被引量:85
  • 2Song E, Lee SK, Wang J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis [J]. Nat Med, 2003, 9(3):347-351
  • 3Chen Z, Vamey ML, Backora MW, et al. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival [J]. Cancer Res., 2005, 65(19):9004-9011
  • 4Durcan N, Murphy C, Cryan SA. Inhalable siRNA: potential as a therapeutic agent in the lungs [J]. Mol Pharm, 2008,5(4):559-566
  • 5Aigner A. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs [J]. J Biotechnol., 2006.,124(1): 12-25
  • 6Xie FY, Woodle MC, Lu PY. Harnessing in vivo siRNA delivery for drug discovery and therapeutic development [J]. Drug Discov Today, 2006 11(1-2):67-73
  • 7Schiffelers RM, Xu J, Storm G, et al. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis [J]. Arthritis Rheum, 2005,52(4): 1314-1318
  • 8Abbas-Terki T, Blanco-Bose W, De glon N, et al. Lentiviral-mediated RNA interference [J]. Hum Gene Ther, 2002,13(18):2197-2201
  • 9Duxbury MS, Ito H, Benoit E, Zinner MJ,,et al Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer [J]. Surgery, 2004,136(2):261-269
  • 10Devroe E, Silver PA. Retrovirus-delivered siRNA [J]. BMC Biotechnol, 2002, 2:15

共引文献12

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部